SCHEMBL14549430

SCHEMBL14549430

Cc1noc(C)c1-c1cc(C)c2ncnnc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 5/20 0.48
▸ BRD4 O60885 9/20 0.46
▸ BRD2 P25440 3/20 0.41
▸ CREBBP Q92793 2/20 0.41
▸ CYP1A2 P05177 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ HIF1A Q16665 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CLK4 Q9HAZ1 2/20 0.40
▸ ERN1 O75460 1/20 0.40
▸ BRD3 Q15059 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4270915 0.76 SRC (0.63) SRCBRD4BRD2ERN1BRD3
SCHEMBL15095284 0.75 SRC (0.40) SRC
SCHEMBL17698634 0.69 BRD4 (0.63) BRD4BRD2CREBBPERN1BRD3
SCHEMBL16132522 0.67 BRD4 (0.54) BRD4BRD2CREBBPERN1BRD3
SCHEMBL15782904 0.66 BRD4 (0.62) BRD4BRD2CREBBPERN1BRD3
SCHEMBL16132488 0.66 FTO (0.49) BRD4BRD2ERN1BRD3
SCHEMBL20362718 0.66 BRD4 (0.49) BRD4BRD2CREBBPERN1BRD3
SCHEMBL4272365 0.66 SRC (1.00) SRCBRD4BRD2BRD3
SCHEMBL9932071 0.66 BRD4 (0.57) BRD4BRD2CREBBPERN1BRD3
SCHEMBL18635203 0.65 BRD4 (0.51) BRD4BRD2CREBBPERN1BRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809614-B1 BENZOTRIAZINE INHIBITORS OF KINASES TARGEGEN INC (US) 2014-05-07 — — EP disclosed
EP-2543376-A1 Benzotriazine inhibitors of kinases Targegen, Inc. (US) 2013-01-09 — — EP disclosed
Send feedback